Search for Clinical Trial Results
Leishmaniasis - 87 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condition: Visceral Leishmaniasis Date: 2012-03-27 Interventions: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
Terminated |
Study Name: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condition: Visceral Leishmaniasis Date: 2011-03-07 Interventions:
|
Terminated |
Study Name: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2008-05-20 Interventions:
|
Completed |
Study Name: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia Condition: Cutaneous Leishmaniasis Date: 2005-09-28 Interventions:
|
Recruiting |
Study Name: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Condition: Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days |
Completed |
Study Name: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol Condition: Leishmaniasis, Cutaneous Date: 2007-05-29 Interventions:
|
Available |
Study Name: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2012-06-18 Interventions: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
Completed |
Study Name: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2005-05-23 Interventions: Biological: Leish-111f + MPL-SE vaccine |
Terminated |
Study Name: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2010-06-07 Interventions: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
Completed |
Study Name: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) Condition: Leishmaniasis, Cutaneous Date: 2009-12-14 Interventions:
|